Cargando…
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic
In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients during this challenging time. We followed the cur...
Autores principales: | Talaulikar, Dipti, Advani, Ranjana H., Branagan, Andrew R., Buske, Christian, Dimopoulos, Meletios A., D'Sa, Shirley, Kersten, Maria J., Leblond, Veronique, Minnema, Monique C., Owen, Roger G., Palomba, Maria Lia, Tedeschi, Alessandra, Trotman, Judith, Varettoni, Marzia, Vos, Josephine M., Treon, Steven P., Kastritis, Efstathios, Castillo, Jorge J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410025/ https://www.ncbi.nlm.nih.gov/pubmed/32803133 http://dx.doi.org/10.1097/HS9.0000000000000433 |
Ejemplares similares
-
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022) -
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study
por: Buske, Christian, et al.
Publicado: (2022) -
Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia
por: Castillo, Jorge J., et al.
Publicado: (2023) -
Managing Waldenström’s macroglobulinemia with BTK inhibitors
por: Buske, Christian, et al.
Publicado: (2022) -
SARS-CoV-2 Infection in Patients With Waldenström’s Macroglobulinemia: A Multicenter International Cohort Study
por: Defrancesco, Irene, et al.
Publicado: (2023)